- Home
- ERAS vs SAFE Comparison
ERAS vs SAFE Comparison
Compare ERAS & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERAS | SAFE |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ERAS | SAFE |
|---|---|---|
| Price | $13.56 | $14.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 11 |
| Target Price | $11.38 | ★ $18.82 |
| AVG Volume (30 Days) | ★ 3.7M | 249.9K |
| Earning Date | 03-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.85% |
| EPS Growth | ★ 36.23 | 7.43 |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | ★ $385,552,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | $9.21 |
| Revenue Growth | N/A | ★ 5.43 |
| 52 Week Low | $1.01 | $12.76 |
| 52 Week High | $16.14 | $19.21 |
Technical Indicators
Market Signals| Indicator | ERAS | SAFE |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 40.08 |
| Support Level | $1.50 | $13.48 |
| Resistance Level | $16.14 | $15.31 |
| Average True Range (ATR) | 1.03 | 0.40 |
| MACD | -0.38 | -0.16 |
| Stochastic Oscillator | 20.16 | 8.50 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.